15th October 2009 - News release


Phytopharm have claimed that Cogane has reversed the effects of Parkinson's Disease. However, the study did not measure the long term effects, and the full details of the clinical trial have not been made available for analysis. For more information go to their News release. Cogane, which can be taken orally, readily crosses the blood-brain barrier and has been shown to stimulate the release of GDNF. GDNF can indirectly stimulate the formation of dopamine, the substance whose insufficiency causes Parkinson's Disease.  For more information go to Cogane

However, GDNF deficiency has never been shown to be the cause of Parkinson's Disease. GDNF was shown to be ineffective in clinical trials in humans. Although Phytopharm claim that Cogane can reverse the effects of Parkinson's Disease, Cogane has never reversed the effects of Parkinson's Disease in anyone. The efficacy study was only carried out on Macaque monkeys. Macaque monkeys do not have Parkinson's Disease. What is described as Parkinson's Disease in monkeys is usually only drug induced. For more current news go to Parkinson's Disease News.


E-MAIL NOTIFICATION : If you would like to be notified by e-mail when any new research, news reports, new books, or new resources are added to Parkinson's Disease News,  please double click on  E-MAIL NOTIFICATION, or e-mail [email protected].  No form of identity is required.  E-mail addresses are not used for any other purpose.

Parkinson's Disease News details all significant new research, news reports, new books, and new resources concerning Parkinson's Disease and those medical disorders that often coincide with Parkinson's Disease. It is compiled from an analysis of  all newly published research, news reports, new clinical trials, all newly published books, and new web sites. A summary and analysis of the new research are provided,  as well as links to the complete abstracts and news reports.





2006-2009  Viartis
2015-11-10 13:22:17
[email protected]